[Pathogenesis and therapy of ascites in liver cirrhosis].
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000471:Alkalosis / Q000150:complications; D001201:Ascites / Q000150:complications* / Q000209:etiology / Q000628:therapy; D003677:Deficiency Diseases / Q000150:complications; D004032:Diet; D004231:Diuresis; D004232:Diuretics / Q000627:therapeutic use*; D005665:Furosemide / Q000627:therapeutic use; D007010:Hyponatremia / Q000150:complications; D008103:Liver Cirrhosis / Q000378:metabolism*; D009318:Natriuresis; D011188:Potassium / Q000652:urine; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
D004232:Diuretics; D013148:Spironolactone; D005665:Furosemide; D011188:Potassium; D014223:Triamterene
Die Pathogenese und Therapie des Ascites bei der Lebercirrhose.